InvestorsHub Logo
Followers 104
Posts 4948
Boards Moderated 0
Alias Born 10/20/2015

Re: blanka post# 183631

Monday, 03/04/2019 2:22:48 PM

Monday, March 04, 2019 2:22:48 PM

Post# of 464403
Muscarinic receptor is listed first. Where have I heard that before? Oh yes the Muscinic receptor drug platform licenced from Heptares by Allegan for a ultimate value of $3.5 billion plus royalties.
So remind me why the rumour of $3.25 billion offer by Biogen and counter of $7..50 by Anavex. Is that out of line given the Allegan/Heptares LICENCE only deal? There was only Phase One data on the Heptares drug. Allergan explained it as the Muscinic receptor activity was highly selective.
But get this: A2-73 concomitantly activates M-1 and Sigma One.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News